Insider Trading Alert - EBIO, SWK And RSG Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 11, 2015, 93 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,570.00 to $275,612,220.00.

Highlighted Stocks Traded by Insiders:

Eleven Biotherapeutics (EBIO) - FREE Research Report

JAFCO Super V3 Investment Limited Partnership, who is 10% Owner at Eleven Biotherapeutics, sold 33,400 shares at $13.23 on May 11, 2015. Following this transaction, the 10% Owner owned 1.9 million shares meaning that the stake was reduced by 1.71% with the 33,400-share transaction.

The shares most recently traded at $13.28, up $0.05, or 0.38% since the insider transaction. Historical insider transactions for Eleven Biotherapeutics go as follows:

  • 4-Week # shares sold: 17,900
  • 12-Week # shares sold: 17,900
  • 24-Week # shares sold: 162,900

The average volume for Eleven Biotherapeutics has been 99,400 shares per day over the past 30 days. Eleven Biotherapeutics has a market cap of $260.9 million and is part of the health care sector and drugs industry. Shares are up 13.38% year-to-date as of the close of trading on Monday.

Eleven Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of protein therapeutics to treat eye diseases primarily in the United States. The company develops its therapeutics through AMP-Rx, a proprietary protein engineering platform. Currently, there are 2 analysts who rate Eleven Biotherapeutics a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EBIO - FREE

TheStreet Quant Ratings rates Eleven Biotherapeutics as a sell. The area that we feel has been the company's primary weakness has been its deteriorating net income. Get the full Eleven Biotherapeutics Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Stanley Black & Decker (SWK) - FREE Research Report

Bontrager D Brett, who is President, Vertical Markets at Stanley Black & Decker, sold 15,000 shares at $103.20 on May 11, 2015. Following this transaction, the President, Vertical Markets owned 20,225 shares meaning that the stake was reduced by 42.58% with the 15,000-share transaction.

The shares most recently traded at $103.15, down $0.05, or 0.05% since the insider transaction. Historical insider transactions for Stanley Black & Decker go as follows:

  • 4-Week # shares sold: 26,301
  • 12-Week # shares sold: 48,472
  • 24-Week # shares sold: 69,455

The average volume for Stanley Black & Decker has been 1.1 million shares per day over the past 30 days. Stanley Black & Decker has a market cap of $15.9 billion and is part of the industrial goods sector and industrial industry. Shares are up 7.55% year-to-date as of the close of trading on Monday.

Stanley Black & Decker, Inc. provides power and hand tools, mechanical access solutions, and electronic security and monitoring systems for various industrial applications. The stock currently has a dividend yield of 2.01%. The company has a P/E ratio of 19.2. Currently, there are 4 analysts who rate Stanley Black & Decker a buy, no analysts rate it a sell, and 11 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SWK - FREE

TheStreet Quant Ratings rates Stanley Black & Decker as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, expanding profit margins, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Stanley Black & Decker Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Republic Services (RSG) - FREE Research Report

Cascade Investment Llc, who is 10% Owner at Republic Services, bought 1.4 million shares at $40.05 on May 11, 2015. Following this transaction, the 10% Owner owned 108.8 million shares meaning that the stake was boosted by 1.26% with the 1.4 million-share transaction.

The shares most recently traded at $40.04, down $0.01, or 0.03% since the insider transaction. Historical insider transactions for Republic Services go as follows:

  • 4-Week # shares bought: 600,000
  • 4-Week # shares sold: 8,270
  • 12-Week # shares bought: 600,000
  • 12-Week # shares sold: 8,270
  • 24-Week # shares bought: 600,000
  • 24-Week # shares sold: 8,270

The average volume for Republic Services has been 1.6 million shares per day over the past 30 days. Republic Services has a market cap of $14.1 billion and is part of the industrial goods sector and materials & construction industry. Shares are up 0.05% year-to-date as of the close of trading on Monday.

Republic Services, Inc., together with its subsidiaries, provides non-hazardous solid waste collection, transfer, recycling, and disposal services for commercial, industrial, municipal, and residential customers in the United States. It operates through three segments: East, Central, and West. The stock currently has a dividend yield of 2.78%. The company has a P/E ratio of 24.4. Currently, there are 5 analysts who rate Republic Services a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RSG - FREE

TheStreet Quant Ratings rates Republic Services as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, reasonable valuation levels, expanding profit margins and good cash flow from operations. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Republic Services Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

ETF Outlook: Winners and Losers In a Trump Presidency

ETF Outlook: Winners and Losers In a Trump Presidency

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Eleven Biotherapeutics (EBIO) Stock Increases, Buys Viventia Bio

Eleven Biotherapeutics (EBIO) Stock Increases, Buys Viventia Bio

It May Be Dull, but That's No Reason to Be Negative

It May Be Dull, but That's No Reason to Be Negative

Don't Roll the Dice on Central Bank News

Don't Roll the Dice on Central Bank News